Targeting of superoxide dismutase to the liver results in anti- inflammatory effects in rats with fibrotic livers

Journal of Hepatology

Volumn 31, Issue 6, 1999, Pages 1034-1043

  Swart, Pieter J ^a,c   Hirano, Takashi ^b   Kuipers, Mirjam E ^a   Ito, Yuko ^b   Smit, Catharina ^a   Hashida, Mitsuru ^d   Nishikawa, Makiya ^d   Beljaars, Leonie ^a   Meijer, Dirk K F ^a   Poelstra, Klaas ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NATL INST BIOSCI HUM TECHNOL   (Japan)

^c Pieter J Swart   (Netherlands)

^d NONE

Author keywords

Bile duct ligated rats; DIVEMA SOD; Kinetics; Man SOD; Oxide radical scavenging; SOD; Superoxide dismutase

Indexed keywords

MANNOSIDE; PYRAN COPOLYMER; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MALE; NEUTROPHIL; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; SCAVENGING SYSTEM;

EID: 0032737432     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80316-X     Document Type: Article

References (45)

1. Day CP. Is necroinflammation a prerequisite for fibrogenesis? Hepatogastroenterology. 43:1997;104-120.
2. Tsukamoto H. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol. 10:1993;465-467.
3. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med. 22:1997;287-305.
4. Chen MF, Mo LR, Lin RC, Kuo JY, Chang KK, Liao C, et al. Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis. Free Radic Biol Med. 23:1997;672-679.
5. Casini A, Ceni E, Salzano R, Biondi P, Parola M, Galli A, et al. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology. 25:1997;361-367.
6. Funatsu K, Ueno M, Mizuno Y, Nishida J, Oda M, Tsuchiya M. Hepatocellular injury due to active oxygen radicals produced by rat liver macrophages. Wisse E, Knook DL, McCuskey RS. Cells of the Hepatic Sinusoid, vol. 3. 1991;73-77 Kupffer Cell Foundation, Leiden.
7. Takeyama Y, Kamimura S, Kuroiwa A, Sohda T, Irie M, Shijo H, et al. Role of Kupffer cell-derived reactive oxygen intermediates in alcoholic liver disease in rats in vivo. Alcohol Clin Exp Res. 20:1996;335A-339A.
8. Fraser R, Dobbs BR, Rogers GWT, Rogers GW. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology. 21:1995;863-874.
9. Tsukamoto H, Rippe R, Niemela O, Lin M. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol. 10:1995;S50-S53.
10. Parola M, Leonarduzzi G, Robino G, Albano E, Poli G, Dianzani MU. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic Biol Med. 20:1996;351-359.
11. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen alpha-1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology. 19:1994;1262-1271.
12. Brown KE, Poulos JE, Li L, Soweid AM, Ramm GA, O'Neill R, et al. Effect of vitamin E supplementation on hepatic fibrogenesis in chronic dietary iron overload. Am J Physiol. 272:1997;G116-G123.
13. Ham AJ, Liebler DC. Antioxidant reactions of vitamin E in the perfused rat liver: product distribution and effect of dietary vitamin E supplementation. Arch Biochem Biophys. 339:1997;157-164.
14. Pastor A, Collado PS, Almar M, Gonzalez Gallego J. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol. 27:1997;363-370.
15. Conforti A, Caliceti P, Sartore L, Schiavon O, Veronese F, Velo GP. Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats. Pharmacol Res. 23:1991;51-56.
16. Bobek G, Scott CD, Baxter RC. Radioimmunoassay of soluble insulin-like growth factor-II/mannose 6-phosphate receptor: developmental regulation of receptor release by rat tissues in culture. Endocrinology. 130:1992;3387-3394.
17. Bayati A, Källskog O, Odlind B, Wolgast M. Plasma elimination kinetics and renal handling of copper/zinc superoxide dismutase in the rat. Acta Physiol Scand. 134:1988;65-74.
18. Mihara K, Oka Y, Sawai K, Takakura Y, Hashida M. Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol. J Drug Target. 2:1994;317-321.
19. Muizelaar JP, Marmarou A, Young HF, Choi SC, Wolf A, Schneider RL, et al. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg. 78:1993;375-382.
20. Morpurgo E, Cadrobbi R, Morpurgo M, Rigotti P, Schiavon F, Schiavon O, et al. Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury. Transplantation. 62:1996;1221-1223.
21. Mihara K, Sawai K, Takahura Y, Hashida M. Manipulation of renal disposition of human recombinant superoxide dismutase by chemical modification. Biol Pharm Bull. 17:1994;296-301.
22. Hirano T, Todoroki T, Kato S, Yamamoto Y, Caliceti P, Veronese F, et al. Synthesis of the conjugate of superoxide dismutase with the copolymer of divinyl ether and maleic anhydride retaining enzymatic activity. J Contr Rel. 28:1994;203-209.
23. McCord JM, Fridovich I. Superoxide dismutase. An enzyme function for erythrocuperein (henmocuprein). J Biol Chem. 244:1969;6049-6055.
24. Lee YC, Stowell CP, Krantz MJ. 2-imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins. Biochem. 15:1976;3956-3963.
25. Fujita T, Nishikawa M, Tamaki C, Takakura Y, Hashida M, Sezaki H. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J Pharmacol Exp Ther. 263:1992;971-978.
26. 131I labelled human growth hormone of high specific radioactivity. Biochem J. 89:1963;114-123.
27. Hinz S, Franke H, Machnik G, Muller A, Dargel R. Histological and biochemical changes induced by total bile duct ligation in the rat. Exp Toxicol Pathol. 49:1997;281-288.
28. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 65:1984;305-311.
29. Proost JH, Meijer DKF. MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med. 22:1992;155-163.
30. Sheiner LB, Beal SL. A note on confidence intervals with extended least squares parameter estimates. J Pharmacokinet Biopharm. 15:1987;93-98.
31. Swart PJ, Beljaars E, Pasma A, Smit C, Schuitemaker H, Meijer DKF. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA. J Drug Target. 4:1996;109-116.
32. Jansen RW, Molema G, Harms G, Kruijt JK, Van Berkel TJC, Hardonk MJ, et al. Formaldehyde treated albumin contains monomeric and polymeric forms that are differently cleared by endothelial and Kupffer cells of the liver: evidence for scavenger receptor heterogeneity. Biochem Biophys Res Commun. 180:1991;23-32.
33. Harms G, Dijkstra CD, Lee YC, Hardonk MJ. Glycosyl receptors in macrophage subpopulations of rat spleen and lymph node. A comparative study using neoglycoproteins and monoclonal antibodies ED1, ED2 and ED3. Cell Tissue Res. 262:1990;35-40.
34. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW. Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int. 37:1990;1500-1508.
35. Briggs RT, Robinson JM, Karnovsky ML, Karnovsky MJ. Superoxide production by polymorphonuclear leukocytes; a cytochemical approach. Histochemistry. 84:1986;371-378.
36. Mori K, Kawasaki T, Yamashina I. Identification of the mannanbinding protein from rat livers as a hepatocyte protein distinct from the mannan receptor on sinusoidal cells. Arch Biochem Biophys. 222:1983;542-552.
37. Dumoulin M-J, Chahine R, Atanasiu R, Nadeau R, Mateescu M-A. Comparative antioxidant and cardioprotective effects of ceruloplasmin, superoxide dismutase and albumin. Arzneimittelforschung. 46:1996;855-861.
38. Adachi T, Fukuta M, Ito Y, Hirano K, Sugiura M, Sugiura K. Effect of superoxide dismutase on glomerular nephritis. Biochem Pharmacol. 35:1986;341-345.
39. Davis JM, Rosenfeld WN, Koo HC, Gonenne A. Pharmacologic interactions of exogenous lung surfactant and recombinant human Cu/Zn superoxide dismutase. Pediatr Res. 35:1994;37-40.
40. Baret A, Jadot G, Michelson AM. Pharmacokinetic and antiinflammatory properties in the rat of superoxide dismutases (Cu SODs and Mn SOD) from various species. Biochem Pharmacol. 33:1984;2755-2760.
41. Furitsu H, Ogawara K, Fujita T, Yamashita F, Takakura Y, Sezaki H, et al. Pharmacokinetic analysis of scavengerreceptor-mediated uptake of anionized proteins in the isolated perfused rat liver. Int J Pharm. 151:1997;15-26.
42. Zidenberg-Cherr S, Keen CL, Lönnerdal B, Hurley LS. Dietary superoxide dismutase does not affect tissue levels. Am J Clin Nutr. 37:1983;5-7.
43. Takakura Y, Masuda S, Tokuda H, Nishikawa M, Hashida M. Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanism. Biochem Pharmacol. 47:1994;853-858.
44. Nakae D, Yamamoto K, Yoshiji H, Kinugasa T, Maruyama H, Farber JJ, et al. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am J Pathol. 136:1990;787-795.
45. Caliceti P, Schiavon O, Hirano T, Ohashi S, Veronese FM. Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the co-polymer of divinyl ether and maleic anhydride. J Contr Rel. 39:1996;27-34.